Organigram Holdings Inc. (TSE:OGI – Get Free Report)’s share price fell 4.5% during trading on Monday . The company traded as low as C$2.10 and last traded at C$2.10. 270,900 shares were traded during trading, an increase of 37% from the average session volume of 197,452 shares. The stock had previously closed at C$2.20.
Analyst Ratings Changes
A number of brokerages recently commented on OGI. ATB Capital dropped their price target on Organigram from C$5.25 to C$3.50 in a report on Tuesday, December 17th. Canaccord Genuity Group reduced their price target on Organigram from C$3.60 to C$3.15 and set a “speculative buy” rating for the company in a research report on Monday, December 9th.
Get Our Latest Stock Analysis on Organigram
Organigram Stock Performance
Organigram Company Profile
Organigram Inc is a Canadian licensed producer of cannabis products. Organigram focuses on producing exceptional, indoor-grown cannabis for patients and adult recreational consumers, as well as developing global business partnerships.
Featured Articles
- Five stocks we like better than Organigram
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- How to Invest in Small Cap Stocks
- Election Stocks: How Elections Affect the Stock Market
- These Are the Dividend Stocks Insiders Bought in January
- What Are Some of the Best Large-Cap Stocks to Buy?
- How the ‘No Buy’ Trend of 2025 Is Boosting These 3 Stocks
Receive News & Ratings for Organigram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organigram and related companies with MarketBeat.com's FREE daily email newsletter.